The startup develops regenerative technologies that create a living nerve growth guide for peripheral nerve repair, providing an off-the-shelf alternative to nerve allografts. This approach eliminates the need for a second surgery to harvest peripheral nerve tissue, facilitating nerve regeneration and functional recovery in patients with nerve injuries.
Funding
$260K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Peripheral nerve injuries, often resulting from trauma, surgery, or compression, can lead to loss of sensation and muscle control, causing chronic pain and disability. Current treatments, such as nerve autografts, require harvesting a nerve from another part of the body, leading to donor site morbidity and limited tissue availability. Alternative options like hollow tubes or decellularized tissue lack the crucial living cells needed to effectively guide nerve regeneration across a gap.
Solution
Glialign develops Engineered Neural Tissue (EngNT), a living nerve growth guide designed as an off-the-shelf solution for peripheral nerve repair. EngNT mimics the structure of a nerve, containing aligned therapeutic cells within a natural gel material and outer sheath, tailored to specific sizes. This engineered tissue supports and guides nerve regeneration, promoting functional recovery by bridging gaps in damaged nerves. By providing a readily available alternative to autografts, EngNT aims to reduce the need for secondary surgeries, lower costs, and improve clinical outcomes for patients with nerve injuries.
Target Audience
The primary target audience includes surgeons and medical professionals specializing in peripheral nerve repair, as well as hospitals and clinics treating patients with nerve injuries resulting from trauma, surgery, or compression.
Features
- Living nerve growth guide containing aligned therapeutic cells within a natural gel matrix.
- Mimics nerve structure to support and guide nerve regeneration across gaps.
- Off-the-shelf availability eliminates the need for a second surgery to harvest nerve tissue.
- Can be tailored to specific sizes to accommodate varying nerve defects.
- Designed to improve functional recovery and reduce chronic pain associated with nerve injuries.